AeroLeads people directory · profile
Kathryn H. Ching, Ph.D. Email & Phone Number
Senior Manager, Molecular Biology
at
OmniAb, Inc.
1 work email found
@ligand.com
LinkedIn matched
✓ Verified August 2026
4 data sources
Profile completeness 100%
Current company
Role
Senior Manager, Molecular Biology
Location
Oakland, California, United States
Company size
Who is Kathryn H. Ching, Ph.D.? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Kathryn H. Ching, Ph.D. is listed as Senior Manager, Molecular Biology at OmniAb, Inc., a with 84 employees, based in Oakland, California, United States. AeroLeads shows a work email signal at ligand.com and a matched LinkedIn profile for Kathryn H. Ching, Ph.D..
Kathryn H. Ching, Ph.D. previously worked as Associate Director at Nextvivo and Senior Scientist at Nextvivo. Kathryn H. Ching, Ph.D. holds Ph.D., Biochemistry And Molecular Biology from Georgetown University.
Company email context
Email format at OmniAb, Inc.
This section adds company-level context without repeating Kathryn H. Ching, Ph.D.'s masked contact details.
*@ligand.com
68% confidence
AeroLeads found 1 current-domain work email signal for Kathryn H. Ching, Ph.D.. Compare company email patterns before reaching out.
Profile bio
About Kathryn H. Ching, Ph.D.
I am a molecular biologist with over 15 years of experience in academia and the pharmaceutical industry dedicated to the development of better diagnostics and treatments for human disease. At the National Institutes of Health (NIDCR), I designed and built immunoassays for a novel luminescent platform to quantitatively measure disease-specific serological markers in cancer and autoimmune disease. The platform, Luciferase Immunoprecipitation Systems (LIPS), has been used extensively by researchers across the NIH and by external partners. Over 60 peer-reviewed publications describe its use. At Crystal Bioscience, I contributed to the design, development and characterization of a humanized chicken for therapeutic antibody discovery. The OmniChicken™ and Crystal Bioscience, Inc. were acquired by Ligand Pharmaceuticals, Inc. in 2017. In 2021, I joined NextVivo, a seed-stage company founded by Stanford University professors Mark Davis and Calvin Kuo and backed by Khosla Ventures. As an Associate Director at NextVivo, I led a team of scientists using patient derived organoids to develop personalized cell therapies and antibody therapeutics.
Listed skills include Molecular Cloning, Pcr, Western Blotting, Elisa, and 6 others.
Current workplace
Kathryn H. Ching, Ph.D.'s current company
Company context helps verify the profile and gives searchers a useful next step.
Omniab, Inc.
8 roles
Kathryn H. Ching, Ph.D. work experience
A career timeline built from the work history available for this profile.
Associate Director
NextVivo was founded in 2021 based on work by Stanford professors Calvin Kuo and Mark Davis with the aim of using patient-derived organoids (PDOs) to develop the next generation of cell therapies and immunotherapies. PDOs grown on an air-liquid interface (ALI), developed in the Kuo lab, recapitulate the complete tumor microenvironment and will allow us to selectively enrich and reinvigorate tumor specific T cells.
Senior Scientist
Sep 2021 - Apr 2024
Research Investigator
At Ligand Pharmaceuticals (formally Crystal Bioscience), I worked on the development of the first transgenic chickens carrying fully human V-regions. The engineering effort and characterization of the animals is described in several peer-reviewed publications. Through external partnerships, the OmniChicken®️ has been used in multiple therapeutic antibody discovery programs.
Oct 2019 - Oct 2021
Senior Scientist
Oct 2017 - Oct 2019
Senior Scientist
Crystal Bioscience (Acquired By Ligand Pharmaceuticals, 2017)
Aug 2013 - Oct 2017
Jul 2011 - Aug 2013
Postdoctoral Fellow
Neurobiology and Pain Therapeutics Section, Laboratory of Sensory BiologyNational Institute of Dental and Craniofacial ResearchBiomarker discovery and immunoassay development in autoimmune and infectious disease.
Sep 2008 - Jun 2011
4 education records
Kathryn H. Ching, Ph.D. education
Ph.D., Biochemistry And Molecular Biology
B.S., Biochemistry
Education record
Education record
FAQ
Frequently asked questions about Kathryn H. Ching, Ph.D.
Quick answers generated from the profile data available on this page.
What company does Kathryn H. Ching, Ph.D. work for?
Kathryn H. Ching, Ph.D. works for OmniAb, Inc..
What is Kathryn H. Ching, Ph.D.'s role at OmniAb, Inc.?
Kathryn H. Ching, Ph.D. is listed as Senior Manager, Molecular Biology at OmniAb, Inc..
What is Kathryn H. Ching, Ph.D.'s email address?
AeroLeads has found 1 work email signal at @ligand.com for Kathryn H. Ching, Ph.D. at OmniAb, Inc..
Where is Kathryn H. Ching, Ph.D. based?
Kathryn H. Ching, Ph.D. is based in Oakland, California, United States while working with OmniAb, Inc..
What companies has Kathryn H. Ching, Ph.D. worked for?
Kathryn H. Ching, Ph.D. has worked for Omniab, Inc., Nextvivo, Ligand Pharmaceuticals, Crystal Bioscience (Acquired By Ligand Pharmaceuticals, 2017), and Usda.
How can I contact Kathryn H. Ching, Ph.D.?
You can use AeroLeads to view verified contact signals for Kathryn H. Ching, Ph.D. at OmniAb, Inc., including work email, phone, and LinkedIn data when available.
What schools did Kathryn H. Ching, Ph.D. attend?
Kathryn H. Ching, Ph.D. holds Ph.D., Biochemistry And Molecular Biology from Georgetown University.
What skills is Kathryn H. Ching, Ph.D. known for?
Kathryn H. Ching, Ph.D. is listed with skills including Molecular Cloning, Pcr, Western Blotting, Elisa, Tissue Culture, Bioconjugate Chemistry, Monoclonal Antibody Development, and Lateral Flow Immunoassay Development.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial